Quince Therapeutics QNCX
NASDAQ QNCX
$33.93 +1.82 (+5.67%)
At close: Aug 21, 2026 · 4:00 PM EDT

Quince Therapeutics (QNCX) Property, Plant & Equipment (Net) (2018 - 2026)

Quince Therapeutics (QNCX) Property, Plant & Equipment (Net) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Quince Therapeutics 203.43 Mn 203.43 Mn - 506,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 550,000.00
Mar 31, 2026 550,000.00
Dec 31, 2025 595,000.00
Dec 31, 2025 595,000.00
Sep 30, 2025 616,000.00
Sep 30, 2025 616,000.00
Jun 30, 2025 573,000.00
Jun 30, 2025 573,000.00
Mar 31, 2025 448,000.00
Mar 31, 2025 448,000.00
Dec 31, 2024 315,000.00
Dec 31, 2024 315,000.00
Sep 30, 2024 208,000.00
Sep 30, 2024 208,000.00
Jun 30, 2024 246,000.00
Jun 30, 2024 246,000.00
Mar 31, 2024 234,000.00
Mar 31, 2024 234,000.00
Dec 31, 2023 234,000.00
Dec 31, 2023 234,000.00